Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study
IntroductionProlactin-secreting pituitary tumors (PRL-omas) are generally benign neoplasia. However, a percentage of cases show aggressive behavior. Prognostic markers may allow for the identification of aggressive cases. In this study, we investigated the prognostic role of galectin-3 and the estro...
Main Authors: | Chiara Bima, Sabrina Chiloiro, Antonella Giampietro, Marco Gessi, Pier Paolo Mattogno, Liverana Lauretti, Carmelo Anile, Guido Rindi, Alfredo Pontecorvi, Laura De Marinis, Antonio Bianchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.684055/full |
Similar Items
-
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors
by: Pier Paolo Mattogno, et al.
Published: (2021-06-01) -
Prolactinomas: Aspectos neurocirúrgicos Prolactinomas: neurosurgical aspects
by: Oswaldo Inácio Tella Jr, et al.
Published: (2002-03-01) -
Combined surgical and medical treatment of giant prolactinoma
by: Mugurel Rădoi, et al.
Published: (2016-06-01) -
Prolactinoma y embarazo
by: Carolina Fux Otta, et al.
Published: (2015-09-01) -
Temozolomide in treatment resistant prolactinomas
by: V. N. Shree, et al.
Published: (2018-08-01)